Systemic levels of IL-17A are significantly elevated in the serum of patients with T2D DR [31] and in T1D DR [32] as well as in PBMCs of T2D patients with no DR [8] compared to controls. This evidence concerns the gene IL17A and type 1 diabetes mellitus.